Multiple Year (2006 ~ 2010) Child Asthma Call-back Survey Prevalence Tables

Return to list of ACBS tables

TABLE 10. Estimated percent using inhaled short acting beta agonists among children1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2006-2010
State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 125 46.8 7.3 (32.5 – 61.1) 149 40.1 6.4 (27.6 – 52.6)
California 170 57.0 5.1 (47.0 – 67.0) 206 51.2 4.8 (41.8 – 60.6)
Connecticut 347 53.6 3.6 (46.5 – 60.7) 413 47.4 3.3 (40.9 – 53.9)
District of Columbia 114 48.3 6.0 (36.5 – 60.1) 140 42.3 5.2 (32.1 – 52.5)
Georgia 341 43.3 3.7 (36.0 – 50.6) 399 38.9 3.3 (32.4 – 45.4)
Hawaii 417 34.6 2.9 (28.9 – 40.3) 444 33.5 2.8 (28.0 – 39.0)
Illinois 168 48.4 5.0 (38.6 – 58.2) 196 43.0 4.6 (34.0 – 52.0)
Indiana 348 46.9 3.6 (39.8 – 54.0) 391 40.3 3.3 (33.8 – 46.8)
Iowa 249 44.9 3.6 (37.8 – 52.0) 274 40.7 3.4 (34.0 – 47.4)
Kansas 588 53.8 2.4 (49.1 – 58.5) 657 48.8 2.3 (44.3 – 53.3)
Louisiana 107 32.2 5.4 (21.6 – 42.8) 122 29.5 5.0 (19.7 – 39.3)
Maine 284 54.8 3.4 (48.1 – 61.5) 332 47.2 3.1 (41.1 – 53.3)
Maryland 385 48.3 3.4 (41.6 – 55.0) 467 39.5 3.0 (33.6 – 45.4)
Massachusetts 269 46.6 4.5 (37.8 – 55.4) 315 41.8 4.0 (34.0 – 49.6)
Michigan 480 45.9 3.0 (40.0 – 51.8) 533 43.6 2.8 (38.1 – 49.1)
Mississippi 80 31.9 6.1 (19.9 – 43.9) 94 28.5 5.3 (18.1 – 38.9)
Missouri 230 51.2 4.7 (42.0 – 60.4) 255 46.1 4.5 (37.3 – 54.9)
Montana 210 46.7 4.4 (38.1 – 55.3) 253 42.2 4.0 (34.4 – 50.0)
Nebraska 467 47.2 3.9 (39.6 – 54.8) 528 43.4 3.7 (36.1 – 50.7)
New Hampshire 150 48.9 5.1 (38.9 – 58.9) 173 44.4 4.8 (35.0 – 53.8)
New Jersey 296 38.6 4.0 (30.8 – 46.4) 337 35.3 3.7 (28.0 – 42.6)
New Mexico 234 45.9 4.5 (37.1 – 54.7) 262 41.9 4.2 (33.7 – 50.1)
New York 276 42.7 4.2 (34.5 – 50.9) 336 35.4 3.7 (28.1 – 42.7)
North Dakota 98 46.7 5.7 (35.5 – 57.9) 120 36.7 5.1 (26.7 – 46.7)
Ohio 222 43.2 4.8 (33.8 – 52.6) 258 36.6 4.4 (28.0 – 45.2)
Oklahoma 250 53.0 3.9 (45.4 – 60.6) 256 52.4 3.9 (44.8 – 60.0)
Oregon 193 44.1 4.4 (35.5 – 52.7) 224 44.7 4.2 (36.5 – 52.9)
Pennsylvania 134 49.5 5.9 (37.9 – 61.1) 156 42.4 5.3 (32.0 – 52.8)
Rhode Island 153 51.5 4.8 (42.1 – 60.9) 180 47.8 4.4 (39.2 – 56.4)
Texas 479 41.5 3.8 (34.1 – 48.9) 558 34.9 3.3 (28.4 – 41.4)
Utah 368 49.4 3.7 (42.1 – 56.7) 414 46.2 3.5 (39.3 – 53.1)
Vermont 389 52.4 3.0 (46.5 – 58.3) 443 48.3 2.8 (42.8 – 53.8)
Virginia 88 44.7 6.6 (31.8 – 57.6) 100 42.6 6.2 (30.4 – 54.8)
Washington 341 49.0 3.5 (42.1 – 55.9) 389 44.4 3.3 (37.9 – 50.9)
West Virginia 193 48.6 4.3 (40.2 – 57.0) 213 45.3 4.0 (37.5 – 53.1)
Wisconsin 147 51.6 5.4 (41.0 – 62.2) 206 43.4 4.4 (34.8 – 52.0)
36 state total 9,390 46.8 1.1 (44.6 – 49.0) 10,793 41.5 1.1 (39.3 – 43.7)
Median 47.1 42.5
Range 31.9-57.0 28.5-52.4

1 Aged < 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.

§ Standard error

Confidence interval

View Page In:Cdc-pdf PDF [201K]
Page last reviewed: September 30, 2012